edg-7500
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 14, 2023 (NCT06011317)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07034768 | Phase 1 | Jul 22, 2025 | Edgewise Therapeutics, Inc. |
| NCT06738836 | Phase 1 | Dec 31, 2024 | Edgewise Therapeutics, Inc. |
| NCT06347159 | Phase 2 | Apr 11, 2024 | Edgewise Therapeutics, Inc. |
| NCT06011317 | Phase 1 | Aug 14, 2023 | Edgewise Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1